Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants
Beate Kampmann, Shabir A. Madhi, Iona Munjal, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 16, pp. 1451-1464
Open Access | Times Cited: 498

Showing 1-25 of 498 citing articles:

Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults
Edward E. Walsh, Gonzalo Pérez Marc, Agnieszka Zareba, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 16, pp. 1465-1477
Closed Access | Times Cited: 344
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
Katherine E. Fleming-Dutra, Jefferson M. Jones, Lauren E. Roper, et al.
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 72, Iss. 41, pp. 1115-1122
Open Access | Times Cited: 120
Respiratory syncytial virus infection and novel interventions
Annefleur C. Langedijk, Louis Bont
Nature Reviews Microbiology (2023) Vol. 21, Iss. 11, pp. 734-749
Closed Access | Times Cited: 80
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
Rose G Bender, Sarah Brooke Sirota, Lucien R Swetschinski, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. 974-1002
Open Access | Times Cited: 68
RSV Prefusion F Protein–Based Maternal Vaccine — Preterm Birth and Other Outcomes
Ilse Dieussaert, Joon Hyung Kim, Sabine Luik, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 11, pp. 1009-1021
Closed Access | Times Cited: 56
Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
Xanthippi Topalidou, Alexis M. Kalergis, Georgios Papazisis
Pathogens (2023) Vol. 12, Iss. 10, pp. 1259-1259
Open Access | Times Cited: 51
Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data
Xin Wang, You Li, Ting Shi, et al.
The Lancet (2024) Vol. 403, Iss. 10433, pp. 1241-1253
Open Access | Times Cited: 48
Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccine
Ye Che, Alexey V. Gribenko, Xi Song, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 693
Closed Access | Times Cited: 45
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis
Joseph A. Lewnard, Esmita Charani, Alec Gleason, et al.
The Lancet (2024) Vol. 403, Iss. 10442, pp. 2439-2454
Closed Access | Times Cited: 45
Two centuries of vaccination: historical and conceptual approach and future perspectives
David A. Montero, Roberto Vidal, Juliana Velasco, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 29
Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination
David Hodgson, N. P. Wilkins, Edwin van Leeuwen, et al.
The Lancet Regional Health - Europe (2024) Vol. 38, pp. 100829-100829
Open Access | Times Cited: 26
Deviations in RSV epidemiological patterns and population structures in the United States following the COVID-19 pandemic
Estefany Rios-Guzman, Lacy M. Simons, Taylor J. Dean, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 25
Nonadjuvanted Bivalent Respiratory Syncytial Virus Vaccination and Perinatal Outcomes
Moeun Son, Laura E. Riley, Anna P. Staniczenko, et al.
JAMA Network Open (2024) Vol. 7, Iss. 7, pp. e2419268-e2419268
Open Access | Times Cited: 17
Respiratory Syncytial Virus Infection in Older Adults: An Update
Franco Alfano, Tommaso Bigoni, Francesco Paolo Caggiano, et al.
Drugs & Aging (2024) Vol. 41, Iss. 6, pp. 487-505
Open Access | Times Cited: 14
Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine
Shabir A. Madhi, Beate Kampmann, Eric A. F. Simões, et al.
Obstetrics and Gynecology (2025)
Closed Access | Times Cited: 2
Burden of RSV infections among young children in primary care: a prospective cohort study in five European countries (2021–23)
Sarah F Hak, Valérie D. V. Sankatsing, Joanne Wildenbeest, et al.
The Lancet Respiratory Medicine (2025)
Closed Access | Times Cited: 2
Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial
Eric A. F. Simões, Barbara Pahud, Shabir A. Madhi, et al.
Obstetrics and Gynecology (2025)
Closed Access | Times Cited: 1
Attitude to RSV Vaccination Among a Cohort of Pregnant Women in Jordan: A Cross‐Sectional Survey Study
Malik Sallam, Tleen Kherfan, Amwaj Al‐Farajat, et al.
Health Science Reports (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
The recent landscape of RSV vaccine research
Karen Kelleher, N. Subramaniam, Simon B. Drysdale
Therapeutic Advances in Vaccines and Immunotherapy (2025) Vol. 13
Open Access | Times Cited: 1
Overview of mucosal immunity and respiratory infections in children: a focus on Africa
Richard K. Mwape, Mikhail Barday, Marieke M. van der Zalm, et al.
Current Opinion in Pediatrics (2025)
Closed Access | Times Cited: 1
A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
Min Lin, Yifan Yin, Xiaomeng Zhao, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Maternal RSV vaccine: Further analysis is urged on preterm births
Hristio Boytchev
BMJ (2023), pp. p1021-p1021
Open Access | Times Cited: 37
Pediatric RSV-Associated Hospitalizations Before and During the COVID-19 Pandemic
Malou Bourdeau, Nirma Khatri Vadlamudi, Nathalie Bastien, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2336863-e2336863
Open Access | Times Cited: 36
The road to approved vaccines for respiratory syncytial virus
Tracy J. Ruckwardt
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 31
Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study
Affan Shoukat, Elaheh Abdollahi, Alison P. Galvani, et al.
The Lancet Regional Health - Americas (2023) Vol. 28, pp. 100629-100629
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top